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ABSTRACT
Bronchoalveolar lavage (BAL) is a simple, yet informative tool in understanding the immunopathology of various lung 
diseases via quantifying various inflammatory cells, cytokines and growth factors. At present, this traditional method is 
often blended with several robust and sophisticated molecular and biological techniques sustaining the significance and 
longevity of this technique. Crucially, the existence of slightly distinct approaches and variables employed at different 
laboratories around the globe in performing BAL aspiration indeed demands an utmost need to optimize and develop 
an effective, cost-effective and a reproducible technique. This mini review will be of importance to the biological trans-
lational scientist, particularly respiratory researchers in understanding the fundamentals and approaches to apply and 
consider with BAL aspiration techniques. This will ensure generating a meaningful and clinically relevant data which in 
turn accelerate the development of new and effective therapeutic moieties for major respiratory conditions.
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INTRODUCTION
Globally, chronic respiratory diseases such as asthma, chronic ob-
structive pulmonary disease (COPD) and cystic fibrosis are among the 
leading causes of mortality and morbidity. Currently available treatments 
for these diseases only focus on alleviating various symptoms instead 
of completely preventing/treating the diseases, which warrants ongoing 
investigations for novel targeted treatments [1]. To establish an effec-
tive therapeutic moiety for various lung diseases, it is crucial to have a 
thorough knowledge on various cellular and immunological processes 
and parameters in lungs [2,3]. One such approach includes sampling 
bronchoalveolar lavage fluid (BALf), which aids in the assessment of 
immune cells, as well as various cytokines and mediators produced by 
these immune cells and the respiratory epithelial cells.
With bronchoalveolar lavage (BAL) method, various cellular and 
non-cellular components from the respiratory tract (epithelial lining fluid) 
can be recovered [4]. Despite being a traditional approach, it avoids 
lung biopsies in various human diseases like pulmonary proteinosis, 
alveolar haemorrhage and eosinophilic pneumonia. Apart from these, 
the application of BAL includes diagnosis of various infectious diseas-
es such as ventilator-associated pneumonia, mycobacterial infection, 
aspergillus fumigatus infection, pneumocystis pneumonia, chlamydia 
pneumoniae pneumonia, cryptococcal infection and non-infectious dis-
eases like idiopathic lung fibrosis, connective tissue disorders, alveolar 
haemorrhage, alveolar proteinosis, etc.
The historical concept of BAL started in early 1920s, when it was 
found particularly useful in the treatment of phosgene gas poisoning 
[5]. At present, evaluation of BAL remains one of the most commonly 
employed techniques in both diagnosis and research in respiratory 
disorders to gain meaningful cytological information [6,7]. The major 
advantage of collecting BALf is minimal invasion of patient, which is 
the most important basis of human and veterinary medicine [8].
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Despite the immense clinical utility of BAL in the evaluation of 
respiratory diseases, our understanding is limited to establishing and 
optimizing a simple, effective, affordable and reliable BAL aspiration 
method at laboratory scale. Thus, it is of utmost importance to review 
the currently employed common practices of BAL acquisition in lab-
oratory animals and how this useful technique enables the in-depth 
understanding of respiratory diseases and research. This mini review 
primarily focuses on the importance and approaches employed in 
various published studies for BAL collection and will benefit various 
biological translational and medical researchers, particularly in the field 
of respiratory diseases.
CLINICAL UTILITY OF BALf COLLECTION
The BALf collection in human patients involve inserting a flexible 
tube connected to a mini-camera (commonly known as fiberoptic 
bronchoscope) into the trachea to enable real-time visualization and 
operating the instrument at the appropriate site, post administration of 
local anesthesia [9]. Rosell et al. also recommended using plastic tub-
ing between the 50 ml syringe and the working channel of the flexible 
bronchoscope when carrying out manual instillation and suction [10]. In 
most cases, three to five aliquots of 50 ml of sterile, phosphate-buffered 
saline solution at 37°C is instilled and after each instillation, the fluid 
is gently aspirated with a negative pressure of −40 to −50 mm Hg [11]. 
Recently, a systemic review of published literature upto 2016 concluded 
that the process of collecting BALf via flexible bronchoscope in humans 
is generally safe, however, it also asserted the need of more research to 
document complications of procedure in greater details [12].
The main rationale and objective for collecting the BALf from widely 
used mice models of respiratory diseases is to evaluate differential cell 
counts, which is clinically significant in understanding and underpinning 
various process and mechanisms involved in inflammation, primarily 
at cellular level, but also in elucidating disease pathology at large [13-
17]. This is an approach which also helps in obtaining a correlation 
between the BAL differential cell counts and various airway respon-
siveness parameters such as airway resistance, diffusing capacity of 
the lungs for carbon monoxide (DLCO) etc., which ultimately predicts 
the pathophysiological consequences occurring during various stages 
of the chronic inflammatory airway diseases.
Several attempts have been made to critically evaluate various 
aspiration techniques to optimize and have a reliable approach for the 
collection of BALf in various animal models of airway diseases. One 
such study by Woods et al. [8] involved collection the BALf using 
manual aspiration (MA) and suction pump aspiration (SPA) in dogs 
with pulmonary disease, and then comparing the sample quality of the 
collected BALf. They have shown that SPA aids in better BALf retrieval 
than MA, however, it does not affect the diagnostic parameters. Similarly, 
Hoffman have investigated various sampling techniques and developed 
guidelines for cytologic preparation and analysis in equine airways [18].
Many researchers have postulated various methods to carry out in-
tubation of the mouse lung in order to assess both pulmonary function 
and BAL in the individual mice with longitudinal studies [19-23]. Such 
techniques appear to be largely successful but they are quite expensive 
and require intense training for the operator. Notably, Das et al. reported a 
simplified approach for intubating mice in longitudinal studies where the 
study involved limited number of expensive research animals [24]. They 
demonstrated usage of fiber-optic light source to visualize trachea which 
makes the technique convenient to the researcher and aids in measure-
ment of lung mechanisms for relatively longer duration (approximately 
several weeks) [24]. Crucially, this method could facilitate repeated 
BALf collection in rats that could reveal real time cellular/cytokine 
profile changes in the models of chronic respiratory diseases [25].
Maxeiner and co-workers standardized a method in murine model 
of lung carcinoma and melanoma which assists in understanding and 
analyzing various cells and released mediators in natural state [26]. 
Analyzing BALf is one of the prime parameters to understand the under-
lying disease pathology in prominent mice models of major respiratory 
diseases, including asthma [27-29], COPD [30,31], and pulmonary 
fibrosis [32]. Moreover, the application of BALF is not only restricted 
to quantifying the inflammatory cells, it is also employed to determine 
the viral titre in various viral infections [3,30].
VARIABLES AFFECTING BALf COLLECTION
The most common problem encountered by researchers during the 
BALf collection is the variability in the sampling volume [33], which, 
in turn, significantly affects the amount of cells and fluid returned. It 
has also been reported that various sections of the lungs have dissimilar 
BALf findings [34,35]. There are various factors which may explain this 
variability (Table 1) such as: the underlying disease [36], amount and 
the nature of instillation used [37], size of syringes [38,39], amount of 
“dwell” time of instillation before aspiration [38-41], extent of pressure 
used while carrying out the BALf collection [42], number of aliquots 
and handling of the collected BALf. Importantly, there are set of rec-
ommendations been laid down by The European Respiratory Society 
(ERS) which clearly explains the major causes of the variability and 
the strategies to overcome these variabilities [43], as well as various 
methods to perform BAL [44,45].
Table 1. Various factors causing variability with bronchoalveolar lavage 
sampling.
Serial No. Factor causing variability with BAL sampling
1 The underlying disease
2 Extent of pressure applied while collecting BALf
3 Amount and nature of instillation used
4 Number of aliquots
5 Size of syringes used
6 Amount of “dwell” time of instillation before aspiration
7 Handling and storage of collected BALf
The various solution and media generally employed for collecting 
BALf include normal sterile saline (0.9% NaCl) [46]/phosphate buffer 
saline (PBS) [47,48] and Hanks buffered salt solution (HBSS) [49]. 
Also, the volume and number of aliquots employed for BAlf varies 
from one study to another, ranging from 500 µl [47] to 1000 µl [49]. 
All these parameters need to be thoroughly considered based on the 
previously reported studies to ensure the reproducibility and accuracy 
of the BALf technique.
Song et al. standardized BAL method based on the suction frequency 
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number and lavage fraction number in rats [50]. Similarly, Singletary 
et al. [41] compared two different aspiration techniques: conventional 
method which involves the use of syringe by manually installing and 
aspirating the fluid and modified method where insertion of a sterile 
intravenous extension tubing was done between the syringe tip and 
bronchoscope biopsy channel. Among both the methods, the modi-
fied method was found to be statistically significant in the amount of 
instillation collected and cells recovered (8.3% increase) as compared 
to the conventional method, which proved to be highly reproducible 
and of clinical importance in understanding the disease pathology [41].
RECENT DEVELOPMENTS IN BALf ANALYSIS
The recent advances in the BALf analysis include the proteomic 
analysis of various proteins which have provided information on the 
mechanism involved with ultrafine carbon black-induced lung injury 
in mice [51]. Remarkably, considerable progress has been made in the 
development of a validated computer program based on polychotomous 
logistic regression model, which is a validated model and have better 
diagnostic power of BALf analysis and reliable prediction of the cur-
rent diagnosis in patients with interstitial lung diseases [52,53]. Such 
models can also be efficiently employed in various translational studies 
where the set of reliable and reproducible BALf data can be obtained.
Radhakrishnan et al. briefed a translational research on BALf which 
have provided a detailed information on the identification of clinically 
relevant microbiologic pathogen and cellular analysis in pediatric 
respiratory diseases [54]. Also, a candidate molecular biomarkers in 
idiopathic pulmonary fibrosis (IPF) namely, S100A9 protein is been 
identified in the BALf proteins [55]. Additionally, Correlating Out-
comes With Biochemical Markers to Estimate Time to Progression in 
Idiopathic Pulmonary Fibrosis (COMET) study [56-58] analysis with 
BAlf have shown an association in the development of IPF and presence 
of Staphylococcus and Streptococcus genera [57] in the United States. 
Furthermore, Molyneaux and co-workers have shown increased patho-
genic load of Haemophilus, Streptococcus, Neisseria and Veillonella 
spp. in IPF patients as compared to control groups (healthy smokers, 
non-smokers, and patients with moderate COPD) [59].
Ortea et al. had used SWATH MS data-independent acquisition and 
targeted data extraction where they have discovered a protein biomarker 
in BALf which can be used in the diagnosis, prognosis and subtyping 
of lung cancer including the treatment response monitoring [60]. All 
such listed BAlf analysis studies have provided a great platform and 
foundation for understanding various other respiratory diseases so as 
to identify the mechanisms involved and new therapeutic interventions.
CONCLUSION AND FUTURE PROSPECTS
BAL is an extremely important respiratory clinical sample and is 
useful in extracting a great level of information on the disease markers 
by blending with various modern and sophisticated molecular and 
biological techniques like –omics approach such as proteomic and 
transcriptomics analysis (aids in establishing the detailed mapping of 
the cellular output and gene displays in the BAL fluid and cells in both 
naïve and patient group) [61,62], enzyme-linked immunosorbent assay 
(ELISA) [63], flow cytometric analysis [64], immunohistochemistry [65], 
quantitative polymerase chain reaction, (qPCR) [66] mass spectropho-
tometry [67,68] and nuclear magnetic resonance (NMR) [68] (Table 2). 
Optimizing BALf collection and combining it with modern advanced 
techniques would ensure higher sensitivity in diagnosing and evaluating 
a variety of inflammatory processes in lungs by quantifying the differ-
ent inflammatory cells, assessing various inflammatory cytokines and 
growth factor expression to underpin the mechanism involved, disease 
features and pathology.
Table 2. Advances in analysis of bronchoalveolar lavage.
      BAL aspiration
Conventional approaches Modern approaches
Cytology Proteomic analysis
Enzyme-linked immunosorbent assay
Flow cytometric analysis
Immunohistochemistry
Quantitative polymerase chain reaction
Mass spectrophotometry
Nuclear magnetic resonance
Remarkably, various special cell types such as dendritic cells could 
also be specifically isolated from BALf which would further our un-
derstanding on specific innate immune pathways [69-71].
In order to have a clinically relevant and meaningful data, it is es-
sential to validate and standardize the lavage process and subsequent 
handling/processing to warrant greater reproducibility and minimum 
variability for future applications in respiratory research. The recent 
advances in technology, various computer assisted programs also have 
enhanced reproducibility and accuracy in the BALf aspiration techniques.
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